Sharp Therapeutics
Pittsburgh
About Sharp Therapeutics
Sharp Edge Labs, Inc. engages in developing biosensors for cellular biology research and high-throughput screening. The company’s products include targeted biosensors to the cellular biology research community. It offers its products based on the fluorogenic activating proteins that provide a detection method for cellular changes, which is amendable to high-throughput screening and follow-up. The company was incorporated in 2011 and is based in Pittsburgh, Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $7.6M
- Funding stage: IPO
- Last round: Post-IPO Debt (Feb 2026)
- Ticker: cve:SHRX
- Website: sharptx.com
- Phone: (412)475-9733
Industries & Categories
Biotechnology, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sharp-therapeutics-44915 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.